BiotechTube
Home/Fortress Biotech/Joseph R. G. Pia
JR

Joseph R. G. Pia

Chief Operating Officer

Fortress Biotech

Therapeutic Areas

OncologyRare DiseasesDermatologyNeurologyInfectious DiseasesPain ManagementRheumatology

Fortress Biotech Pipeline

DrugIndicationPhase
ZYCUBO® (CUTX-101)Menkes DiseaseMarketed
UNLOXCYT™ (cosibelimab-ipdl)Cutaneous Squamous Cell Carcinoma (cSCC)Marketed
Emrosi™RosaceaMarketed
Qbrexza®Primary Axillary HyperhidrosisMarketed
CAEL-101AL AmyloidosisPhase 3
DotinuradGout & Chronic Kidney DiseasePhase 3
IV TramadolPost-Operative Acute PainNDA Filed
Triplex VaccineCMV in Transplant RecipientsPhase 2

Leadership Team at Fortress Biotech

LA
Lindsay A. Rosenwald, M.D.
Chairman, President & Chief Executive Officer
MS
Michael S. Weiss
Executive Vice Chairman & Strategic Advisor
DM
David M. Mace
Chief Financial Officer
View full Fortress Biotech profile